BIOSYENT INC earnings per share and revenue

RX earnings per share for the last quarter are 0.13 CAD whereas the estimation was 0.13 CAD which accounts for 0.00% surprise. Company revenue for the same period amounts to 8.94 M CAD despite the estimated figure of 8.80 M CAD. Estimated earnings per share for the next quarter are 0.14 CAD, and revenue is expected to reach 9.00 M CAD. Also watch annual changes over time to get a bigger picture of RX earnings per share and revenue dynamics.